Are you feeling anything yet?
Those in the mood to discuss a productâ€™s merits or dangers can find no argument more fertile than that over marijuana, increasingly legal on a state level in the U.S. Is the psychoactive substance tetrahydrocannabinol, or THC, addictive, a gateway drug, a miracle cure, no worse than alcohol or some combination of those?
As fraught as that issue has become, the debate is even more confusing over another ingredient of the plant, cannabidiol, or CBD. While it doesnâ€™t get users high or, according to many who have tried it, do anything at all, supporters have made all sorts of claims about its benefits for maladies such as anxiety and arthritis. The substance has even made it into dog treats.
The U.S. Food and Drug Administration convened a hearing on Friday with dozens of speakers, some pro and some con. And the verdict? A leading cannabis exchange-traded fund fell by a little over 5% between Fridayâ€™s open and Mondayâ€™s close. Then investors changed their minds and bid it up by 5%.
Perhaps a warning label is in order: â€śMay cause confusion or indecision.â€ť